A study in people with type 2 diabetes.
- Who can join
- Adults 22 to 65, have type 2 diabetes.
- What you take
- Check ClinicalTrials.gov for this trial's study groups and what each group receives.
- How long it lasts
- The full study runs about 2 years.
- What you get
- Costs vary by study. Ask the study team what this one covers, including the study medicine, visits and travel, before you sign the consent form.
What this study is for
Primary condition: Type 2 Diabetes. Also studied in: Prediabetes, Liver Disease.
Full scientific study title: Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk.
Who can join
Adults 22 to 65, have type 2 diabetes. A site coordinator confirms whether you qualify during a free screening visit. The exact medical requirements are below.
Full medical eligibility (for you and your doctor)verbatim from the registry
This is the exact wording from ClinicalTrials.gov, including clinical measures (lab values, imaging scores). Bring it to your doctor if any of it is unclear.
Key inclusion criteria
- English Proficiency with a Middle-school Reading Level
- Owning a smartphone or obtaining one on-loan basis during the study period, with a data plan and/or the ability to receive text messages
- Possess basic skills to operate an (Android) smartphone, if you want to receive behavior intervention/therapy in addition to the standard care service
- Willingness to Modify Behavior, Physical activity, and diet
- Age 22 to 65
Key exclusion criteria
- Pregnancy (ICD-10 code: Z33.3)
- Receiving Hepatotoxic Medication (ICD-10 code: K76.1)
- Cirrhosis, Hepatitis B/C, and Other Chronic Liver Diseases (ICD-10 code: K.74, B19.10, B19.20, K72.1)
- Cardiovascular Events in the Past 6 Months and Symptomatic Heart Failure (ICD-10 code: I.21, I.25, I.50, I63.9)
- Stage 4 and Above Chronic Kidney Disease (CKD) and End-Stage Renal Disease (ESRD)(ICD-10 code: N18.4, N18.5, N18.6)
Where this trial runs
This trial has 1 sites across 1 state. Site contacts are listed for reference. They are not screening through this trial right now.
New York1 site
- NYC Health + Hospitals/Queens Hospital Center Diabetes Center of ExcellenceJamaica, New York
Timeline
Scheduled start: July 1, 2025. Expected completion: June 30, 2027. Last updated on ClinicalTrials.gov: June 23, 2025.
Official source
Every Monday we check this trial against ClinicalTrials.gov, the federal registry for clinical research. Last checked September 4, 2026. Confirm the current status there before you contact a site:
Other GLP-1 clinical trials
Back to the full directory → or take the matching quiz if you want clinical trials filtered to your conditions and location.
